BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 16, 2002
View Archived Issues
Tranzyme Enters QBI Deal, Targets Neurosensory Drugs
Read More
Hyseq, BASF To Finish Deal Early; Hyseq Cutting Employees
Read More
Second-Generation LongSAGE' Strategists Say 15,000 Genes In Human Genome Still Uncounted
Read More
Nexell's Board OKs Orderly Wind-Down' Of Operations
Read More
Other News To Note
Read More
Corixa Wants Dispute Resolution For Bexxar Through FDAMA
Corixa Corp. said it is requesting an appeal of the FDA's complete review letter questioning the net clinical benefit and safety of the company's lead cancer product, known as Bexxar. (BioWorld Today)
Read More